journal article·2025-12

Ultrasound‐Activated Fe‐Doped Hollow BaTiO 3 Nanoparticles for Targeted Venous Thrombolysis Via Piezo‐Amplified Fenton Catalysis

Mingbo Wu, Dong Li, Yao Liu, Xin Li, Xiaomiao Ruan, Jingwen Yang, Zegang Li, Siyi Chen, Xin Yang, Wenwu Ling

Small· Volume 21· Issue 48
Publisher page

Abstract

Abstract Current thrombolytic drug therapies are challenged by limited circulation time, off‐target effects, and bleeding risks. In this study, multifunctional piezoelectric nanoplatforms are rationally designed for piezoelectric Fenton‐assisted thrombolysis. Piezoelectric hollow barium titanate (hBT) nanoparticles (NPs) are synthesized via template‐assisted etching and Fe‐doping, followed by fucoidan grafting to obtain hBT 3Fe ‐Fu NPs. The hollow structure demonstrated a four‐fold enhancement in piezoelectric response compared to that of solid NPs, and Fe‐doping promoted the formation of oxygen vacancies, regulated the bandgap, and enhanced piezoelectric polarization. Moreover, ultrasound‐triggered piezoelectrons accelerated Fe 3+ /Fe 2+ transformation, synergistically dissolving thrombi with 88.6% efficiency in vitro. In a venous thrombosis model, fucoidan‐mediated active targeting achieved 2.4‐fold greater NP accumulation at the thrombus site. Integrated piezoelectric‐Fenton therapy resulted in complete thrombus dissolution and vessel recanalization while maintaining < 5% bleeding risk and negligible systemic toxicity. The engineered hBT 3Fe ‐Fu nanoplatform represents a promising non‐pharmacological strategy for safe and effective piezocatalytic thrombolytic therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Venous Thromboembolism Diagnosis and Management · Vascular Anomalies and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Ultrasound West China Hospital Sichuan University Chengdu 610041 P. R. China

Department of Oncology General Hospital of Western Theater Command of PLA Chengdu 610083 P. R. China

School of Laboratory Medicine Chengdu Medical College Chengdu 610500 P. R. China

School of Bioscience and Biotechnology Chengdu Medical College Chengdu 610500 P. R. China

Key Laboratory of target discovery and protein drug development in major diseases of Sichuan Higher Education institutes Chengdu Medical College Chengdu 610500 P. R. China

Funding

West China Hospital, Sichuan University

References (49)

Show source-provided references
1. 10.1002/adhm.20220257810.1002/adhm.202202578 ↗
2. 10.1016/j.biomaterials.2024.12246810.1016/j.biomaterials.2024.122468 ↗
3. 10.1002/adfm.20231286610.1002/adfm.202312866 ↗
4. 10.1038/s41467-023-42691-810.1038/s41467-023-42691-8 ↗
5. 10.1038/s41467-023-35895-510.1038/s41467-023-35895-5 ↗
6. 10.1016/j.molliq.2021.11798910.1016/j.molliq.2021.117989 ↗
7. 10.1016/j.cej.2025.16435810.1016/j.cej.2025.164358 ↗
8. 10.1002/smll.20220640110.1002/smll.202206401 ↗
9. 10.1002/anie.20250044110.1002/anie.202500441 ↗
10. 10.1016/j.apcatb.2023.12252010.1016/j.apcatb.2023.122520 ↗
11. 10.1021/acsnano.4c1631410.1021/acsnano.4c16314 ↗
12. 10.1002/adma.20200138510.1002/adma.202001385 ↗
13. 10.1016/j.ccr.2025.21682210.1016/j.ccr.2025.216822 ↗
14. 10.1002/adma.20230426210.1002/adma.202304262 ↗
15. 10.1016/j.cej.2023.14551510.1016/j.cej.2023.145515 ↗
16. 10.1016/j.ceramint.2016.05.02110.1016/j.ceramint.2016.05.021 ↗
17. 10.1016/j.renene.2023.11965310.1016/j.renene.2023.119653 ↗
18. 10.1016/j.bioactmat.2023.11.00410.1016/j.bioactmat.2023.11.004 ↗
19. 10.1002/adfm.20220936510.1002/adfm.202209365 ↗
20. 10.1002/adhm.20230149710.1002/adhm.202301497 ↗
21. 10.1016/j.apcatb.2020.11934010.1016/j.apcatb.2020.119340 ↗
22. 10.1002/smll.20240267910.1002/smll.202402679 ↗
23. 10.1016/j.jiec.2019.05.00710.1016/j.jiec.2019.05.007 ↗
24. 10.1016/j.nanoen.2024.11033410.1016/j.nanoen.2024.110334 ↗
25. 10.1002/adfm.20180198310.1002/adfm.201801983 ↗
26. 10.1016/j.actbio.2022.11.03910.1016/j.actbio.2022.11.039 ↗
27. 10.1002/adfm.20190761910.1002/adfm.201907619 ↗
28. 10.1039/D0TC03519J10.1039/D0TC03519J ↗
29. 10.1021/acs.chemrev.7b0016110.1021/acs.chemrev.7b00161 ↗
30. 10.1002/anie.20230701810.1002/anie.202307018 ↗
31. 10.1016/j.cej.2022.13598210.1016/j.cej.2022.135982 ↗
32. 10.1002/advs.20240628210.1002/advs.202406282 ↗
33. 10.1016/j.jconrel.2021.06.04310.1016/j.jconrel.2021.06.043 ↗
34. 10.1021/acsami.2c1556110.1021/acsami.2c15561 ↗
35. 10.1002/advs.20190137810.1002/advs.201901378 ↗
36. 10.1016/j.cis.2020.10226110.1016/j.cis.2020.102261 ↗
37. 10.2967/jnumed.115.15798210.2967/jnumed.115.157982 ↗
38. 10.1186/s12951-025-03675-610.1186/s12951-025-03675-6 ↗
39. 10.1016/j.cej.2022.13465010.1016/j.cej.2022.134650 ↗
40. 10.1016/j.apcatb.2023.12252010.1016/j.apcatb.2023.122520 ↗
41. 10.1016/j.memsci.2021.11986110.1016/j.memsci.2021.119861 ↗
42. 10.1016/j.biomaterials.2017.04.00610.1016/j.biomaterials.2017.04.006 ↗
43. 10.1016/j.jhazmat.2021.12770210.1016/j.jhazmat.2021.127702 ↗
44. 10.1002/smll.20230032710.1002/smll.202300327 ↗
45. 10.1016/j.nanoen.2022.10697510.1016/j.nanoen.2022.106975 ↗
46. 10.1002/smll.20231219110.1002/smll.202312191 ↗
47. 10.1016/j.cej.2024.14918710.1016/j.cej.2024.149187 ↗
48. 10.1021/acsami.1c1928810.1021/acsami.1c19288 ↗
49. 10.1002/adma.20210995510.1002/adma.202109955 ↗